The comparison with Retatrutide is particularly relevant because both come from Eli Lilly and share the GIP/GLP-1 dual agonist foundation
In a 68-week clinical trial, participants on Wegovy (semaglutide) lost an average of 14.9% body weight compared to 2.4% in the placebo group
Off-label prescribing is legal in the United States, but it raises distinct legal issues
NAC (N-acetylcysteine) and GlyNAC are also excellent choices for those looking to support antioxidant supplements naturally by improving their bodys internal production
In earlier laboratory studies, researchers noticed an increased incidence of a specific type of thyroid cancer called medullary thyroid cancer
VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M